Overview

Comparing Raltegravir Genital Tract Distribution in HIV-infected Men and Women

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine how much raltegravir gets into the male and female genital tract.
Phase:
N/A
Details
Lead Sponsor:
University of Rochester
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Raltegravir Potassium